Amicogen Statistics

Total Valuation

Amicogen has a market cap or net worth of KRW 197.61 billion. The enterprise value is 391.43 billion.

Market Cap	197.61B
Enterprise Value	391.43B

Important Dates

The next estimated earnings date is Friday, January 31, 2025.

Earnings Date	Jan 31, 2025
Ex-Dividend Date	n/a

Share Statistics

Amicogen has 54.82 million shares outstanding. The number of shares has increased by 31.60% in one year.

Current Share Class	n/a
Shares Outstanding	54.82M
Shares Change (YoY)	+31.60%
Shares Change (QoQ)	-0.00%
Owned by Insiders (%)	23.17%
Owned by Institutions (%)	6.43%
Float	42.11M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.19
PB Ratio	1.15
P/TBV Ratio	1.18
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 60.05, with an EV/FCF ratio of -6.28.

EV / Earnings	-10.96
EV / Sales	2.51
EV / EBITDA	60.05
EV / EBIT	n/a
EV / FCF	-6.28

Financial Position

The company has a current ratio of 0.92, with a Debt / Equity ratio of 0.79.

Current Ratio	0.92
Quick Ratio	0.50
Debt / Equity	0.79
Debt / EBITDA	26.55
Debt / FCF	-2.77
Interest Coverage	-0.71

Financial Efficiency

Return on equity (ROE) is -17.20% and return on invested capital (ROIC) is -1.23%.

Return on Equity (ROE)	-17.20%
Return on Assets (ROA)	-0.98%
Return on Capital (ROIC)	-1.23%
Revenue Per Employee	692.17M
Profits Per Employee	-158.67M
Employee Count	225
Asset Turnover	0.33
Inventory Turnover	2.05

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -44.50% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-44.50%
50-Day Moving Average	4,054.30
200-Day Moving Average	5,678.68
Relative Strength Index (RSI)	43.61
Average Volume (20 Days)	297,723

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Amicogen had revenue of KRW 155.74 billion and -35.70 billion in losses. Loss per share was -693.74.

Revenue	155.74B
Gross Profit	49.66B
Operating Income	-7.38B
Pretax Income	-39.97B
Net Income	-35.70B
EBITDA	6.52B
EBIT	-7.38B
Loss Per Share	-693.74

Full Income Statement

Balance Sheet

The company has 26.74 billion in cash and 173.06 billion in debt, giving a net cash position of -146.32 billion or -2,669.30 per share.

Cash & Cash Equivalents	26.74B
Total Debt	173.06B
Net Cash	-146.32B
Net Cash Per Share	-2,669.30
Equity (Book Value)	218.60B
Book Value Per Share	3,121.40
Working Capital	-12.84B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 6.40 billion and capital expenditures -68.78 billion, giving a free cash flow of -62.38 billion.

Operating Cash Flow	6.40B
Capital Expenditures	-68.78B
Free Cash Flow	-62.38B
FCF Per Share	-1,137.90

Full Cash Flow Statement

Margins

Gross margin is 31.89%, with operating and profit margins of -4.74% and -22.92%.

Gross Margin	31.89%
Operating Margin	-4.74%
Pretax Margin	-25.66%
Profit Margin	-22.92%
EBITDA Margin	4.19%
EBIT Margin	-4.74%
FCF Margin	n/a

Dividends & Yields

Amicogen does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-31.60%
Shareholder Yield	-31.60%
Earnings Yield	-19.24%
FCF Yield	-31.56%

Stock Splits

The last stock split was on December 13, 2023. It was a forward split with a ratio of 2.

Last Split Date	Dec 13, 2023
Split Type	Forward
Split Ratio	2

Scores

Amicogen has an Altman Z-Score of 1.02. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.02
Piotroski F-Score	n/a